In contrast, the pharmacological induction of TSLP in epidermal keratinocytes promotes the formation and growth of BRAF melanoma, which normally develops slowly and accelerates the progression and metastasis of BRAF/PTEN melanoma. The gene discussed is TSLP; the disease is melanoma.